Adicet Bio, Inc. (ACET)

NASDAQ: ACET · Real-Time Price · USD

0.7350

-0.0200 (-2.65%)

At close: Apr 1, 2025, 4:00 PM

0.7632

+0.0282 (3.84%)

After-hours: Apr 1, 2025, 4:47 PM EDT

Adicet Bio Employees

Adicet Bio had 152 employees as of December 31, 2024. The number of employees increased by 9 or 6.29% compared to the previous year.

Employees

152

Change (1Y)

9

Growth (1Y)

6.29%

Revenue / Employee

n/a

Profits / Employee

-$770,539

Market Cap

60.77M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	152	9	6.29%
Dec 31, 2023	143	11	8.33%
Dec 31, 2022	132	46	53.49%
Dec 31, 2021	86	4	4.88%
Dec 31, 2020	82	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ACET News

23 hours ago - Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
1 day ago - Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference - Business Wire
25 days ago - Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Business Wire
4 weeks ago - Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting - Business Wire
4 weeks ago - Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc) - Business Wire
7 weeks ago - Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement - Business Wire
2 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
2 months ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference - Business Wire